Clinical Trial Update: TACE as an Adjuvant Therapy After Hepatectomy for HCC [Phase 3]

View source ↗

Summary

This document summarizes a Phase 3 clinical trial evaluating transarterial chemoembolization (TACE) as adjuvant therapy after hepatectomy for hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Jia Fan | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN